FLI1 and Ewing sarcoma: An improved molecule developed starting from NSC635437 has led to [40]: (1) disruption of the interaction between the RNA helicase and EWS–FLI1; (2) apoptosis of cancerous cells; and (3) decrease of tumor volume in Ewing’s sarcoma xenografted mice.